EE03306B1 - Alendronaadi kasutamine osteoporoosi vältimiseks - Google Patents

Alendronaadi kasutamine osteoporoosi vältimiseks

Info

Publication number
EE03306B1
EE03306B1 EE9700308A EE9700308A EE03306B1 EE 03306 B1 EE03306 B1 EE 03306B1 EE 9700308 A EE9700308 A EE 9700308A EE 9700308 A EE9700308 A EE 9700308A EE 03306 B1 EE03306 B1 EE 03306B1
Authority
EE
Estonia
Prior art keywords
alendronate
prevent osteoporosis
osteoporosis
prevent
Prior art date
Application number
EE9700308A
Other languages
English (en)
Estonian (et)
Inventor
John Yates A.
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of EE03306B1 publication Critical patent/EE03306B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EE9700308A 1995-06-02 1996-05-29 Alendronaadi kasutamine osteoporoosi vältimiseks EE03306B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45819595A 1995-06-02 1995-06-02
PCT/US1996/007912 WO1996038156A1 (en) 1995-06-02 1996-05-29 Use of alendronate for the prevention of osteoporosis

Publications (1)

Publication Number Publication Date
EE03306B1 true EE03306B1 (et) 2000-12-15

Family

ID=23819759

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700308A EE03306B1 (et) 1995-06-02 1996-05-29 Alendronaadi kasutamine osteoporoosi vältimiseks

Country Status (21)

Country Link
EP (1) EP0828496A1 (pt)
JP (1) JPH10506648A (pt)
KR (1) KR19990022436A (pt)
CN (1) CN1192685A (pt)
AU (1) AU709196B2 (pt)
BG (1) BG63103B1 (pt)
BR (1) BR9609020A (pt)
CA (1) CA2222318A1 (pt)
CZ (1) CZ381197A3 (pt)
EA (1) EA000677B1 (pt)
EE (1) EE03306B1 (pt)
HU (1) HUP9900659A3 (pt)
IL (1) IL118422A0 (pt)
IS (1) IS4617A (pt)
NO (1) NO975527D0 (pt)
NZ (1) NZ308935A (pt)
PL (1) PL323669A1 (pt)
SK (1) SK159597A3 (pt)
TR (1) TR199701482T1 (pt)
WO (1) WO1996038156A1 (pt)
ZA (1) ZA964465B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
KR100317935B1 (ko) * 1999-10-20 2001-12-22 유승필 대사성 골질환 치료용 약제조성물 및 이의 제조방법
PT1392325E (pt) * 2001-05-02 2006-10-31 Novartis Ag Metodo de administracao de bifosfonatos por inalacao no tratamento ou na prevencao da reabsorcao ossea e da osteoporose
JP2010043119A (ja) * 2009-10-16 2010-02-25 Gador Sa 骨の代謝病の予防および/または治療のための組成物、その組成物の調製方法およびその使用
KR102472749B1 (ko) * 2022-01-18 2022-12-02 주식회사 위엔씨 유해가스제거 및 항균탈취기능을 함유한 흡착소재 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations

Also Published As

Publication number Publication date
CA2222318A1 (en) 1996-12-05
AU5882496A (en) 1996-12-18
NO975527L (no) 1997-12-01
NZ308935A (en) 2000-07-28
IS4617A (is) 1997-11-19
AU709196B2 (en) 1999-08-26
KR19990022436A (ko) 1999-03-25
SK159597A3 (en) 1998-06-03
EP0828496A1 (en) 1998-03-18
HUP9900659A2 (hu) 2001-04-28
BR9609020A (pt) 1999-07-06
BG102060A (en) 1998-07-31
BG63103B1 (bg) 2001-04-30
CN1192685A (zh) 1998-09-09
HUP9900659A3 (en) 2002-12-28
TR199701482T1 (xx) 1998-03-21
PL323669A1 (en) 1998-04-14
EA000677B1 (ru) 2000-02-28
CZ381197A3 (cs) 1998-06-17
NO975527D0 (no) 1997-12-01
IL118422A0 (en) 1996-09-12
ZA964465B (en) 1996-12-11
JPH10506648A (ja) 1998-06-30
WO1996038156A1 (en) 1996-12-05
EA199700449A1 (ru) 1998-06-25

Similar Documents

Publication Publication Date Title
FR2729849B1 (fr) Pansement adhesif
DE59604607D1 (de) Gelenkloses prothesenfussteil
DK0861235T3 (da) Substituerede benzylaminopiperidinforbindelser
DE69607031D1 (de) Reiniger
ATA181095A (de) Probiotisch wirksame formulierung
BR9607427A (pt) Inibiçao de angiogêne usando interleucina 12
IT1276799B1 (it) Formulazioni di f-silicone
EE03306B1 (et) Alendronaadi kasutamine osteoporoosi vältimiseks
FI952707A (fi) Syöttöveden esilämmitinjärjestelmä
FIU950494U0 (fi) Skaerverktyg foer gipsskiva
ATA93795A (de) Befestigungsbinder
NO964685D0 (no) Isomering av equilin
PT761766E (pt) Compostos assimetricos de trifenilenodioxazina
KR960031589U (ko) 보차도 경계석의 연결구
KR960033296U (ko) 욕실 신발
AT204U3 (de) Fussabstreifer
KR970015931U (ko) 분리형 신발
KR970000111U (ko) 도계 설비 시스템의 3차 이양기
KR970000149U (ko) 욕실 신발
KR970011853U (ko) 새로운 형태의 메리야스
ITMI951551A0 (it) Composizioni orosolubili di n-acetilcisteina
KR970010637U (ko) 물분배기의 개폐장치
ITMI950804A0 (it) Composti lattonici utili per il trattamento dell'osteoporosi
ITMI950803A0 (it) Composti lattonici utili per il trattamento dell'osteoporosi
KR970014191U (ko) 체결용 보스의 구조

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

MM4A Lapsed by not paying the annual fees

Effective date: 20030529